TARA Announces Issuance of US Patent for Biowire™ II Platform
May 14, 2019
News
New York, NY, (Newswire.com) - TARA Biosystems, Inc. (TARA), a company offering physiologically relevant human “heart-on-a-chip” tissue models for cardiac risk assessment and drug discovery applications, today announced that the United States Patent and Trademark Office (USPTO) has …
TARA presents at WuXi Healthcare Forum in Shanghai
March 5, 2019
News
TARA presents today at the WuXi Healthcare Forum in Shanghai. The forum brings together 1000+ innovators, entrepreneurs, clinicians, and investors from around the world that are shaping the future of healthcare.
TARA Biosystems Biowire™ II Heart-on-a-Chip Platform Published in CELL
January 24, 2019
News
NEW YORK, (Newswire.com) TARA Biosystems, Inc., a company offering physiologically relevant human “heart-on-a-chip” tissue models for cardiac risk assessment and drug discovery applications, today announced the first peer-reviewed publication of its Biowire™ II platform by a team of …
TARA Biosystems and Insilico Medicine Announce Drug Discovery Collaboration for Cardiac Disease
January 7, 2019
Featured
New York – TARA Biosystems, Inc. a company offering “heart-on-a-chip” tissue models for drug discovery and risk assessment applications and Insilico Medicine, an artificial intelligence company developing end-to-end drug discovery pipelines for age-related diseases, announced today the launch of a collaboration to discover and develop novel therapies for …
TARA Launches Cardiotype.Fo, Best-In-Class Assay for Cardiac Contractility
September 27, 2018
News
New York, (Newswire.com) - TARA Biosystems, Inc. a company offering “heart-on-a-chip” tissue models for drug discovery and development applications announced today the launch of Cardiotype.Fo, the best-in-class in vitro system for assessment of cardiac …